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Data from the Swedish Cancer Register 1987–1996 were used to examine seasonal trends in the diagnosis of cancer. For
melanomas, prostate, breast and thyroid cancer there were clear seasonal variations with reductions in the number of cases reported
during the summer and December that are likely to reflect mainly hospital delays.
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There are reports of seasonal variations in the diagnosis and
reporting of malignant melanomas or pigmented naevi (Swerdlow,
1985; Schwartz et al, 1987; Braun et al, 1994), lymphomas
(Westerbeek et al, 1998), leukaemias (Badrinath et al, 1997;
Eatough, 2002), breast cancer (Cohen et al, 1983; Kirkham et al,
1985; Mason et al, 1990; Ross et al, 1997; Dimitrov et al, 1998; Gao
et al, 2001), and childhood cancers (Ross et al, 1999). Some of
these variations in presentation have intriguing temporal patterns
which reflect either biological phenomena or administrative
differences in the likelihood of tumour detection and registration.
We judged that further exploration of this issue is of interest.
Data from a nationwide Cancer Register provided an opportu-
nity to examine seasonal trends in the diagnosis of cancer in
Sweden by analysing all invasive cancers recorded between 1987
and 1996, a total of more than half a million incident cases.
MATERIAL AND METHODS
The Swedish Cancer Registry was established in 1958 and covers
the whole Swedish population (8.9 million), including foreign
citizens and ethnic minorities with permanent residency.
Reporting of all new cancers and also certain benign tumours is
mandatory, both in public and private care. Separate notifications
should be filed by the clinician as well as by the pathologist/
morphologist, which means that at least two reports per case are
needed before registration. Furthermore, a new report must be
issued if a substantial revision of the original diagnosis is made.
The completeness of recording is estimated to be 95%. Approxi-
mately 97% of all recorded cases are morphologically verified
(Swedish Cancer Registry, 2000).
Since 1985, reports are first sent to one of six regional Cancer
Registries where patient data and tumours are recorded. For each
calendar year, the regional registries submit the material to the
National Cancer Registry for collation, merging of data and
updating of the national files. A coordination group with
representatives from the National Registry and each regional
registry meet regularly to ascertain conformity in coding and data-
processing routines.
The Cancer Registry publishes an annual report with the
numbers of cancers, gender and age-specific and age-standardised
incidence rates. Complete cancer incidence data for each year are
released with about 2 years delay. At present, approximately 45000
incident cases are recorded annually. Date of diagnosis is defined
as the earliest examination date when the cancer was found
(Swedish Cancer Registry, 2000).
The present study analysed tumours reported as definitely
malignant neoplasms, a total of 555948 incident tumours during
the 10-year period 1987–1996. No national information was
available on stage.
STATISTICAL ANALYSES
To detect any deviation from a uniform monthly distribution of
the frequency of cancers by site throughout the year, a w
2 test for
heterogeneity was used. In a subsequent approach, tumour reports
from 1987 to 1996 were modelled by year and month to identify
smooth trends during the years (Bacchetti, 1994). In our analysis,
the temporal trend is a nuisance and was modelled initially both in
continuous (linear and quadratic terms) and in a completely
unstructured way using indicator variables. A better approach is to
use parametric natural cubic B splines with evenly spaced knots
(De Boor, 1978).
Monthly effects were modelled generally as M(j)¼M(jþ12) and
M(1)¼0 for 11 free parameters, or with the following reduced
model:
MðjÞ : s1 sinð2pj=12Þþs2 cosð2pj=12Þþs3 sinð4pj=12Þþs4
  cosð2pj=12Þþtð12   cðjÞÞ=11 þ gIðcðjÞ¼ð 7or8ÞÞ ð1Þ
where c(j) is the calendar month (i.e., 1 if j is January of any year, 2
if j is February, etc.), the s’s model any truly seasonal patterns, t is
the size of the jump between December and January and models
any linear trend over the calendar year, and g is a general summer
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and the seasonal terms (the summer spike). The model uses only
six parameters, instead of the 11 needed for completely arbitrary
month effects, separating seasonal components from other
influences.
Cancer incidence was modelled with both negative binomial
regression to adjust for overdispersion and lack of fit in Poisson’s
regression. For each of the four types of cancers that deviated from
a uniform temporal distribution, the parameter estimates were
adjusted by gender, age and region. Model estimation and fitting
was performed using STATA 7.0 (Stata Corp, 2000).
RESULTS
We first examined the combined monthly distribution for all
cancer sites (ICD-7: 140–209). Malignant melanomas, prostate,
breast and thyroid cancers were the only sites for which a
deviation from a uniform distribution throughout the year could
be detected (Table 1). For melanomas, the number of new cases
reported was lowest during the winter months while monthly
frequencies peaked at two different points: in May–June and
September–October. For prostate, breast and thyroid, there was a
clear decrease in the frequency of new cases diagnosed during the
summer months, followed by a transient increase in subsequent
months. The highest mean number of cases was reported in
October and November for prostate and breast cancer, respec-
tively. For all four cancer types, there was a decrease in December
followed by an increase in January and February. Seasonal
trends (based on 3-months moving averages) are illustrated in
Figure 1.
In a second analytic step, monthly counts from the whole period
of observation were modelled in terms of secular trends and short-
term effects to identify smooth trends over the year, adjusted by
gender, age and region. Table 2 shows a comparison of the relative
seasonal changes in registration. The most pronounced summer
season decrease was seen for melanomas ( 28.4%), while thyroid
cancer had the highest relative increase between December and
January (þ27.6%). When assessed by age at diagnosis, year of
diagnosis, or by health-care region, the observed patterns did not
change (data not shown).
Table 1 Monthly frequency distributions of diagnosis of melanoma, breast, prostate and thyroid cancers in Sweden 1987–1996. w
2 test for heterogeneity
Cancer Jan Feb Mar Apr May June July Aug Sept Oct Nov Dec Mean Total v
2 (d.f.) P-value
Melanoma 1132 1136 1344 1246 1471 1652 1153 1362 1545 1502 1330 1098 1331 15971 277.7 (11) o0.001
Breast 4812 5211 5618 5243 5293 5156 3480 3722 5211 5787 5804 4806 5012 60143 1181.4 (11) o0.001
Prostate 5010 5209 5491 4843 5014 4407 3658 4244 5295 5704 5623 4644 4929 59142 825.8 (11) o0.001
Thyroid 311 355 350 290 282 255 186 222 298 329 295 253 286 3433 98.3 (11) o0.001
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Figure 1 Number of new cancer cases (3-month moving averages) diagnosed in Sweden 1987–1996.
Table 2 Comparison of seasonal changes in cancer incidence estimated
using model (1)
July and August
decrease (c)
January
increase (s)
Type of cancer Estimate (s.e.) Estimate (s.e.)
Melanoma  28.4 4.7 10.6 7.6
Breast  16.7 3.6 20.6 5.6
Prostate  13.1 2.7 17.8 4.1
Thyroid  27.2 9.2 27.6 9.2
The estimates for g can be interpreted as the percentage decrease in July/August, and
for t as the percentage jump from December to January after controlling for seasonal
effects and trend over calendar year.
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For the great majority of cancers, we found a uniform seasonal
distribution of detection. However, for melanomas, prostate,
breast and thyroid cancer there were reductions in the number
of cases diagnosed during the summer and the month of
December.
Melanoma
For melanomas, our results broadly corroborate findings in at least
three earlier studies that found evidence of seasonal patterns of
detection (Swerdlow, 1985; Schwartz et al, 1987; Braun et al, 1994).
At northern latitudes such as in Sweden, an early (May–June) peak
could reflect an increased patient awareness and self-detection of
abnormal naevi coinciding with the change to summer clothing.
The postsummer (September–October) peak may, however, be a
result of a promoting effect of sun exposure, resulting in signs and
symptoms of malignant changes in pre-existing naevi.
Breast cancer
The sharp decrease in the number of new cases of breast cancers
recorded in June and July is likely to reflect mainly the reduced
activity of mammography screening programmes during the
summer months. These programmes were introduced in Sweden
in the late 1980s. By 1993, more than 90% of women of eligible ages
(generally 50–74 years) were invited to regional screening
programmes. However, in a separate analyses of cases recorded
during 1988 and earlier, a similar reduction during the summer
was found. Patients’ delay may also contribute to the summer
decrease. Signs and symptoms are disregarded and not attended to
until after vacation time. The results of earlier studies of possible
seasonality of breast cancer have varied (Cohen et al, 1983;
Kirkham et al, 1985; Mason et al, 1990; Ross et al, 1999; Gao et al,
2001), but none have found a similar pronounced summer
decrease.
Prostate and thyroid cancer
To our knowledge, no previous study has investigated seasonal
variations in the diagnosis of prostate and thyroid cancer. As in the
case of breast cancer, our findings of a decrease during the
summer are likely to reflect a reduced capacity to ascertain
suspected cases within the health-care system.
Our study is the largest reported on this subject so far. It was
based on national cancer register data of high validity to which all
tumours are reported in a country with a uniform national public
health-care system. Given the consistency of our findings when
assessed by region or time period, chance is an unlikely
explanation for the observed patterns. It also appears unlikely
that our results can be explained by systematically delayed
reporting or data entry by season at the regional registries. If this
had occurred, seasonal variations would have been observed for a
broader range of cancers.
In conclusion, our findings of seasonal variations in the
diagnosis of melanomas, thyroid, breast and prostate cancer are
likely to reflect both patient and hospital delay. A common clinical
feature of these four cancers is that they often present with mild,
nonacute symptoms, allowing delay of self-referral. It is also
conceivable that the lower diagnostic intensity during summer and
around the turn of the year reflects a reduced capacity to evaluate
patients with suspected cancers. For melanomas, however, the
bimodal diagnostic pattern would be in keeping with seasonal
exposure to solar radiation.
Overall, the observed variations in detection intensity appear
unlikely to have clinical implications or influence survival
negatively, since very rapid progression is rare in these tumours.
However, any seasonally related delay between first visit, referral
and final diagnosis of cancer because of a reduced capacity within
the health-care system may cause anxiety among patients. Further
efforts to minimise delays are important, for example, by
implementing quality guidelines where patients with a suspected
cancer are guaranteed to be evaluated, diagnosed and treated
within a stipulated time period.
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